Concepedia

Birte K. Skrumsager

BK

10

Publications

740

Citations

10

H-Index

1981

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Peter MacCallum Cancer Centre

Cancer Trials Australia

Austin Health

Birte K. Skrumsager is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1981–2016

10

Publications

10

An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma

Ian D. Davis, Birte K. Skrumsager, Jonathan Cebon et al. · Clinical Cancer Research · 2007 · 164 citations · Full text

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial

Ian D. Davis, Ben Brady, Richard Kefford et al. · Clinical Cancer Research · 2009 · 138 citations

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

Per Karlsson, Lars Farde, Christer Halldin et al. · Psychopharmacology · 1993 · 130 citations · Full text

, , +9

IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma

Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A. Freeman et al. · Cancer Immunology Immunotherapy · 2008 · 114 citations · Full text

A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects

Ulf Søgaard, Bridget Butler, Alex Lund Laursen et al. · International Clinical Psychopharmacology · 1990 · 59 citations

Rows per page

1–5 of 10